{
  "cik": 1404281,
  "cik_padded": "0001404281",
  "entityName": "Eledon Pharmaceuticals, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-116164",
      "filed": "2026-03-19",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 22808000.0,
        "eps_diluted": -0.52,
        "net_income": -45617000.0,
        "operating_cash_flow": -62341000.0,
        "stockholders_equity": 81085000.0,
        "total_assets": 169009000.0,
        "total_liabilities": 32230000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3974841216007893,
        "roa_avg2y": -0.26336695399146687,
        "roa_period_end": -0.26990870308681786,
        "roe_avg2y": -0.6356396875936209,
        "roe_period_end": -0.5625824751803663
      }
    },
    {
      "accn": "0001193125-26-116164",
      "filed": "2026-03-19",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 20549000.0,
        "eps_diluted": -0.66,
        "net_income": -36184000.0,
        "operating_cash_flow": -47271000.0,
        "stockholders_equity": 62446000.0,
        "total_assets": 177405000.0,
        "total_liabilities": 59265000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9490599878294846,
        "roa_avg2y": -0.2715792712903093,
        "roa_period_end": -0.20396268425354416,
        "roe_avg2y": -5.183954154727794,
        "roe_period_end": -0.5794446401691061
      }
    },
    {
      "accn": "0001193125-26-116164",
      "filed": "2026-03-19",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 4612000.0,
        "eps_diluted": -4.73,
        "net_income": -116537000.0,
        "operating_cash_flow": -39527000.0,
        "stockholders_equity": -48486000.0,
        "total_assets": 89066000.0,
        "total_liabilities": 81858000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -1.281619276472432,
        "roa_period_end": -1.308434194866728,
        "roe_avg2y": 9.43695845817475
      }
    },
    {
      "accn": "0001193125-25-180865",
      "filed": "2025-08-14",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 56409000.0,
        "eps_diluted": -6.16,
        "net_income": -87966000.0,
        "operating_cash_flow": -28424000.0,
        "stockholders_equity": 23788000.0,
        "total_assets": 92793000.0,
        "total_liabilities": 8610000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3619472002690432,
        "roa_avg2y": -0.6680767521958222,
        "roa_period_end": -0.9479809899453623,
        "roe_avg2y": -0.9368899208128532,
        "roe_period_end": -3.6979149150832353
      }
    },
    {
      "accn": "0000950170-24-098575",
      "filed": "2024-08-19",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 84833000.0,
        "eps_diluted": -2.33,
        "net_income": -34506000.0,
        "operating_cash_flow": -28913000.0,
        "stockholders_equity": 163995000.0,
        "total_assets": 170548000.0,
        "total_liabilities": 6553000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.039958535321198814,
        "roa_avg2y": -0.18766877054819667,
        "roa_period_end": -0.2023242723456153,
        "roe_avg2y": -0.19462422904134621,
        "roe_period_end": -0.21040885392847344
      }
    },
    {
      "accn": "0001564590-22-011698",
      "filed": "2023-03-30",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 114195000.0,
        "net_income": -22811000.0,
        "operating_cash_flow": -15212000.0,
        "stockholders_equity": 190596000.0,
        "total_assets": 197185000.0,
        "total_liabilities": 6589000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.03457050515225923,
        "roa_avg2y": -0.21921428434142498,
        "roa_period_end": -0.11568324162588432,
        "roe_avg2y": -0.22804044766346265,
        "roe_period_end": -0.119682469726542
      }
    },
    {
      "accn": "0001564590-22-011698",
      "filed": "2022-03-24",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 8791000.0,
        "net_income": -16011000.0,
        "operating_cash_flow": -13857000.0,
        "stockholders_equity": 9465000.0,
        "total_assets": 10931000.0,
        "total_liabilities": 1466000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.15488642366613842,
        "roa_avg2y": -1.145401867153128,
        "roa_period_end": -1.4647333272344707,
        "roe_avg2y": -1.3366448219727012,
        "roe_period_end": -1.6916006339144216
      }
    },
    {
      "accn": "0001564590-21-016828",
      "filed": "2021-03-31",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 12972000.0,
        "net_income": -14065000.0,
        "operating_cash_flow": -11893000.0,
        "stockholders_equity": 14492000.0,
        "total_assets": 17026000.0,
        "total_liabilities": 2534000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.17485509246480818,
        "roa_avg2y": -0.7418640223640487,
        "roa_period_end": -0.8260895101609304,
        "roe_avg2y": -0.8287178882865897,
        "roe_period_end": -0.9705354678443279
      }
    },
    {
      "accn": "0001564590-20-011260",
      "filed": "2020-03-17",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 17233000.0,
        "net_income": -13116000.0,
        "operating_cash_flow": -14941000.0,
        "stockholders_equity": 19452000.0,
        "total_assets": 20892000.0,
        "total_liabilities": 1440000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.07402837754472548,
        "roa_avg2y": -1.18761318362912,
        "roa_period_end": -0.6278001148765078,
        "roe_avg2y": -1.5660895522388059,
        "roe_period_end": -0.6742751388032079
      }
    },
    {
      "accn": "0001564590-19-009631",
      "filed": "2019-03-28",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 1103000.0,
        "net_income": -5655000.0,
        "stockholders_equity": -2702000.0,
        "total_assets": 1196000.0,
        "total_liabilities": 3898000.0
      },
      "period_end": "2016-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-116164",
    "filed": "2026-03-19",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001404281.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001404281.json"
  },
  "ticker": "ELDN"
}